什么是权益披露？Reported on October 29th, according to the documents disclosed by the Hong Kong Stock Exchange on October 29th, Hu Zhengguo increased his shareholding on October 25th at an average price of 2.0335 Hong Kong dollars per share.$CSTONE PHARMA-B (02616.HK)$He increased his shareholding by 0.921 million shares of ordinary shares, worth approximately 1.8729 million Hong Kong dollars. After the shareholding increase, Hu Zhengguo's latest number of shares held is 2.921 million shares, and his shareholding ratio increased from 0.16% to 0.23%.
Supplementary information: Box 28: Restricted share units and share options granted by CStone Pharmaceuticals pursuant to the Post-IPO Incentive Schemes.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
